EMA accepts application for leukaemia drug from Otsuka and Astex
The marketing authorisation application is supported by results from a phase 3 trial for AML
Read More
Tag: Astex Pharmaceuticals
CR UK, Newcastle Uni extend alliance with Astex
Cancer Research UK and Newcastle University have extended their strategic drug discovery alliance with Astex Pharmaceuticals by three years to work on developing new cancer drugs and associated biomarkers.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
